Oral lactoferrin treatment resolves amoebic intracecal infection in C3H/HeJ mice

Biochemistry and Cell Biology

Volumn 90, Issue 3, 2012, Pages 435-441

  León Sicairos, Nidia ^a,b   Martínez Pardo, Leonardo ^c   Sánchez Hernández, Beatriz ^d   De La Garza, Mireya ^e   Carrero, Julio Ćsar ^c  

^a UNIVERSIDAD AUTÓNOMA DE SINALOA   (Mexico)

^b Servicio de Hematología Y Oncología Hospital Pediátrico de Sinaloa Dr Rigoberto Aguilar Pico   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^d INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^e DEPARTAMENTO DE FÍSICA   (Mexico)

Author keywords

Amoebiasis; In vivo; Lactoferrin; Mice; Protection

Indexed keywords

AMOEBIASIS; IN-VIVO; LACTOFERRIN; MICE; PROTECTION;

TISSUE;

MAMMALS;

CYTOKINE; IMMUNOGLOBULIN A; INTERLEUKIN 6; LACTOFERRIN;

AMEBIASIS; AMOEBIC INTRACECAL INFECTION; ANIMAL TISSUE; ARTICLE; CECUM; CYTOKINE RELEASE; DISEASE PREDISPOSITION; DOWN REGULATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFECTION CONTROL; INFLAMMATION; NONHUMAN; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL; TREATMENT OUTCOME; TROPHOZOITE;

ADMINISTRATION, ORAL; AMEBICIDES; ANIMALS; CATTLE; CECUM; CYTOKINES; DRUG EVALUATION, PRECLINICAL; ENTAMOEBA HISTOLYTICA; ENTAMOEBIASIS; HOST-PARASITE INTERACTIONS; IMMUNOGLOBULIN A; INFLAMMATION; LACTOFERRIN; MICE; MICE, INBRED C3H; TH2 CELLS; TREATMENT OUTCOME; TROPHOZOITES;

ANIMALIA; BOVINAE; ENTAMOEBA HISTOLYTICA; MUS; PROTOZOA;

EID: 84861401501     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/o2012-008     Document Type: Article

References (35)

1. Akisu C. Aksoy U. Cetin H. Ustun S. Akisu M. 2004. Effect of human milk and colostrum on Entamoeba histolytica. World J. Gastroenterol. 10 (5): 741-742. 14991951
2. Brock J.H. 2002. The physiology of lactoferrin. Biochem. Cell Biol. 80 (1): 1-6. 10.1139/o01-212 11908632
3. Carrero J.C. Diaz M.Y. Viveros M. Espinoza B. Acosta E. Ortiz-Ortiz L. 1994. Human secretory immunoglobulin A anti-Entamoeba histolytica antibodies inhibit adherence of amebae to MDCK cells. Infect. Immun. 62 (2): 764-767. 8300242
4. Carrero J.C. Cervantes-Rebolledo C. Aguilar-Diaz H. Diaz-Gallardo M.Y. Laclette J.P. Morales-Montor J. 2007. The role of the secretory immune response in the infection by Entamoeba histolytica. Parasite Immunol. 29 (7): 331-338. 10.1111/j.1365-3024.2007.00955.x 17576362
5. Carrero J.C. Contreras-Rojas A. Sanchez-Hernandez B. Petrosyan P. Bobes R.J. Ortiz-Ortiz L. Laclette J.P. 2010. Protection against murine intestinal amoebiasis induced by oral immunization with the 29 kDa antigen of Entamoeba histolytica and cholera toxin. Exp. Parasitol. 126 (3): 359-365. 10.1016/j.exppara.2010.03.007 20303954
6. Drago-Serrano M.E. Rivera-Aguilar V. Resendiz-Albor A.A. Campos-Rodriguez R. 2010. Lactoferrin increases both resistance to Salmonella typhimurium infection and the production of antibodies in mice. Immunol. Lett. 134 (1): 35-46. 10.1016/j.imlet.2010.08.007 20727369
7. Espinosa A. Clark D. Stanley S.L. Jr. 2004. Entamoeba histolytica alcohol dehydrogenase 2 (EhADH2) as a target for anti-amoebic agents. J. Antimicrob. Chemother. 54 (1): 56-59. 10.1093/jac/dkh280 15150165
8. Espinosa-Cantellano M. Martinez-Palomo A. 2000. Recent developments in amoebiasis research. Curr. Opin. Infect. Dis. 13 (5): 451-456. 10.1097/00001432-200010000-00004 11964813
9. Fritsch G. Sawatzki G. Treumer J. Jung A. Spira D.T. 1987. Plasmodium falciparum: inhibition in vitro with lactoferrin, desferriferrithiocin, and desferricrocin. Exp. Parasitol. 63 (1): 1-9. 10.1016/0014-4894(87)90072-5 3542546
10. Ghosh P.K. Mancilla R. Ortiz-Ortiz L. 1994. Intestinal amebiasis: histopathologic features in experimentally infected mice. Arch. Med. Res. 25 (3): 297-302. 7803977
11. Goldman P. 1980. Metronidazole: proven benefits and potential risks. Johns Hopkins Med. J. 147 (1): 1-9. 7382255
12. González-Chávez S.A. Aŕvalo-Gallegos S. Rascón-Cruz Q. 2009. Lactoferrin: strcuture, function and applications. Int. J. Antimicrob. Agents, 33 (4): 301.e1-8. 10.1016/j.ijantimicag.2008.07.020
13. Hartog A. Leenders I. van der Kraan P.M. Garssen J. 2007. Anti-inflammatory effects of orally ingested lactoferrin and glycine in different zymosan-induced inflammation models: evidence for synergistic activity. Int. Immunopharmacol. 7 (13): 1784-1792. 10.1016/j.intimp.2007.09.019 17996689
14. Hirai Y. Kawakata N. Satoh K. Ikeda Y. Hisayasu S. Orimo H. Yoshino Y. 1990. Concentrations of lactoferrin and iron in human milk at different stages of lactation. J. Nutr. Sci. Vitaminol. (Tokyo), 36 (6): 531-544. 10.3177/jnsv.36.531 2097325
15. Jones S.A. 2005. Directing transition from innate to acquired immunity: defining a role for IL-6. J. Immunol. 175 (6): 3463-3468. 16148087
16. Kapoor K. Chandra M. Nag D. Paliwal J.K. Gupta R.C. Saxena R.C. 1999. Evaluation of metronidazole toxicity: a prospective study. Int. J. Clin. Pharmacol. Res. 19 (3): 83-88. 10761537
17. Land K.M. Johnson P.J. 1999. Molecular basis of metronidazole resistance in pathogenic bacteria and protozoa. Drug Resist. Updat. 2 (5): 289-294. 10.1054/drup.1999.0104 11504503
18. León-Sicairos N. López-Soto F. Reyes-Lopez M. Godínez-Vargas D. Ordaz-Pichardo C. de la Garza M. 2006 a. Amoebicidal activity of milk, apo-lactoferrin, sIgA and lysozyme. Clin. Med. Res. 4 (2): 106-113. 10.3121/cmr.4.2.106 16809402
19. León-Sicairos N. Reyes-López M. Ordaz-Pichardo C. de la Garza M. 2006 b. Microbicidal action of lactoferrin and lactoferricin and their synergistic effect with metronidazole in Entamoeba histolytica. Biochem. Cell Biol. 84 (3): 327-336. 16936803
20. Leyva O. Rico G. Ramos F. Moran P. Melendro E.I. Ximenez C. 1992. Inhibition of adhesion process mediated by anti-E ntamoeba histolytica specific monoclonal IgA antibodies. Arch. Med. Res. 23 (2): 227-229. 1340300
21. Lima M.F. Kierszenbaum F. 1985. Lactoferrin effects on phagocytic cell function. I. Increased uptake and killing of an intracellular parasite by murine macrophages and human monocytes. J. Immunol. 134 (6): 4176-4183. 3886800
22. López-Soto F. León-Sicairos N. Nazmi K. Bolscher J.G. de la Garza M. 2010. Microbicidal effect of the lactoferrin peptides lactoferricin17-30, lactoferrampin265-284, and lactoferrin chimera on the parasite Entamoeba histolytica. Biometals, 23 (3): 563-568. 10.1007/s10534-010- 9295-3 20140481
23. Mela I. Aumaitre E. Williamson A.M. Yakubov G.E. 2010. Charge reversal by salt-induced aggregation in aqueous lactoferrin solutions. Colloids Surf. B Biointerfaces, 78 (1): 53-60. 10.1016/j.colsurfb.2010.02.011 20207115
24. Murray M.J. Murray A. Murray C.J. 1980. The salutary effect of milk on amoebiasis and its reversal by iron. BMJ, 280 (6228): 1351-1352. 10.1136/bmj.280.6228.1351 7388537
25. Ochoa T.J. Chea-Woo E. Campos M. Pecho I. Prada A. McMahon R.J. Cleary T.G. 2008. Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children. Clin. Infect. Dis. 46 (12): 1881-1883. 10.1086/588476 18462105
26. Pehrson P. Bengtsson E. 1984. Treatment of non-invasive amoebiasis a comparison between tinidazole and metronidazole. Ann. Trop. Med. Parasitol. 78 (5): 505-508. 6395815
27. Roe F.J. 1983. Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential. Surgery, 93 (1 Pt 2): 158-164. 6336861
28. Soares R.V. Lin T. Siqueira C.C. Bruno L.S. Li X. Oppenheim F.G. et al. 2004. Salivary micelles: identification of complexes containing MG2, sIgA, lactoferrin, amylase, glycosylated proline-rich protein and lysozyme. Arch. Oral Biol. 49 (5): 337-343. 10.1016/j.archoralbio.2003.11.007 15041480
29. Stanley S.L. Jr. 2003. Amoebiasis. Lancet, 361 (9362): 1025-1034. 10.1016/S0140-6736(03)12830-9 12660071
30. Tanaka T. Omata Y. Saito A. Shimazaki K. Igarashi I. Suzuki N. 1996. Growth inhibitory effects of bovine lactoferrin to Toxoplasma gondii parasites in murine somatic cells. J. Vet. Med. Sci. 58 (1): 61-65. 10.1292/jvms.58.61 8645758
31. Tebbutt N.C. Giraud A.S. Inglese M. Jenkins B. Waring P. Clay F.J. et al. 2002. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat. Med. 8 (10): 1089-1097. 10.1038/nm763 12219085
32. Turchany J.M. Aley S.B. Gillin F.D. 1995. Giardicidal activity of lactoferrin and N-terminal peptides. Infect. Immun. 63 (11): 4550-4552. 7591103
33. Wang W.P. Iigo M. Sato J. Sekine K. Adachi I. Tsuda H. 2000. Activation of intestinal mucosal immunity in tumor-bearing mice by lactoferrin. Jpn. J. Cancer Res. 91 (10): 1022-1027. 10.1111/j.1349-7006.2000.tb00880.x 11050473
34. Wassmann C. Hellberg A. Tannich E. Bruchhaus I. 1999. Metronidazole resistance in the protozoan parasite Entamoeba histolytica is associated with increased expression of iron-containing superoxide dismutase and peroxiredoxin and decreased expression of ferredoxin 1 and flavin reductase. J. Biol. Chem. 274 (37): 26051-26056. 10.1074/jbc.274.37.26051 10473552
35. Wershil B.K. Furuta G.T. 2008. 4. Gastrointestinal mucosal immunity. J. Allergy Clin. Immunol. 121 (2 Suppl.): S380-S383, quiz S415. 10.1016/j.jaci.2007.10.023 18241686